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INTRODUCTION
Vestibular schwannomas (VS) are benign tumors arising from 
the Schwann cells of the vestibular nerve. While vestibular 
symptoms are expected from the nerve of origin, auditory 
symptoms such as hearing loss and tinnitus are most common 
symptoms presenting at the time of diagnosis [1]. Patients with 
VS may present with vestibular symptoms of significant vari-
ability in severity and progression; symptoms include vertigo 
and dizziness, and sometimes postural instability [1-7]. The on-
set of the symptoms is variable because the central compensa-
tion may mask the development of slowly ongoing peripheral 
vestibular hypofunction with slow-growing tumors. Gradual de-
terioration of vestibular function eventually leads to postural in-
stability, which poses significant impact on patients’ quality of 
life [8,9]. 
Many researches have focused on the relationship of objective 
parameters such as vestibular function tests and tumor charac-
teristics to explain the wide spectrum of vertigo in VS patients. 
Caloric testing has been the most common method to evaluate 
vestibular function in VS patients, and more recently vestibular 
myogenic evoked potentials (VEMP) and video head impulse 
test (vHIT) have been employed [1,10-14]. Larger tumors have 
been associated with more severe caloric paresis [12,13]. Calor-
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Objectives. Growth of vestibular schwannomas (VS) causes progressive vestibular symptoms and postural instability. Since 
the tumor grows slowly, compensation of decaying vestibular input may decrease subjective symptoms of dizziness. 
This study aims to estimate the relationship of subjective vestibular symptoms and objective postural instability in 
patients with VS. 
Methods. A retrospective review of 18 patients newly diagnosed with VS and with subjective vertigo symptoms was per-
formed. The results of vestibular function tests including the sensory organization test (SOT) using computerized dy-
namic posturography, caloric test, and self-report measures of subjective dizziness handicap (Dizziness Handicap In-
ventory) and visual analogue scale were compared according to the onset of vertigo symptoms. 
Results. In VS patients, SOT showed decreased equilibrium score for all vestibular function related conditions, condition (C) 
5 and 6, and composite (COMP) score. COMP scores were not correlated with visual analogue scale or Dizziness 
Handicap Inventory scores. Acute onset group included six patients and insidious onset group, 12 patients. Equilibri-
um scores for C5 and C6, and COMP scores were lower for insidious onset group, but the difference was not statisti-
cally significant. 
Conclusion. Our findings confirmed postural instability is prevalent in VS patients. SOT parameters did not differ signifi-
cantly between acute onset and insidious onset groups, but increased tumor size and canal weakness were noted in 
the insidious onset group. Clinicians should consider that postural instability is likely present even in patients who do 
not complain of acute vertigo, and appropriate counseling should be discussed with the patients. 
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ic weakness and vHIT abnormality were shown to correlate 
with tumor size, but not with vertigo symptoms in VS patients 
[1,10]. Abnormal in vHIT results were found in VS patients with 
normal caloric responses, suggesting conventional caloric testing 
may not be sensitive to vestibular dysfunction caused by VS 
[11]. It was reported that abnormal vHIT and caloric weakness 
were correlated with tumor size, especially when the large tu-
mors were compressing the brainstem [14]. Abnormalities in 
VEMPs showed correlation to tumor size [4], and a large-scale 
study of VS patients showed that larger tumors were associated 
with higher risk of canal paresis and postural instability [2]. 
Similar to other causes of unilateral vestibular deficit, objective 
dysfunction measured by caloric, vHIT or VEMP in VS patients 
does not necessarily correlate with subjective symptom severity 
or progression. It has been suggested that gradual loss of the pe-
ripheral vestibular input would allow adequate central vestibu-
lar compensation to alleviate vertigo symptoms. 
In addition to adequate vestibular input, visual and somato-
sensory information is required to maintain balance, and the 
computerized dynamic posturography (CDP) can provide an 
objective assessment of the postural stability [6,15]. It can be as-
sumed that postural control will deteriorate with gradual decline 
of vestibular input that will likely occur with tumor growth, 
even if the patient does not experience severe vertigo symp-
toms. The VS with vertigo, dizziness and/or imbalance symp-
toms had lower scores in CDP testing compared with those 
without symptoms [16], and even patients with small tumors 
scored lower than normal subjects [17]. It has been reported 
that only 10% of the variance in subjective vertigo symptom 
can be explained by differences in postural stability [2]. The 
CDP results showed a unique correlation between tumor size 
and postural instability, with increased postural sway when the 
tumor was small, which improved with increased tumor size, 
then again increased postural sway with even larger size of the 
tumor compressing the brainstem [17]. 
Although postural instability in VS patients has been de-
scribed with respect to patient and tumor characteristics, to our 
knowledge, there are few reports to correlate the acuteness of 
the vestibular symptoms to the objective CDP findings in this 
patient population. We hypothesized that the acute vertigo 
symptoms the patients experience might reflect current change 
in vestibular nerve function, while patients who report vestibu-
lar symptoms with insidious progression reflect increased pos-
tural instability. In this study, we analyzed vestibular function 
tests and CDP results in VS patients and their correlation with 
subjective vertigo symptoms.
MATERIALS AND METHODS
The Review Board of the Gangnam Severance Hospital ap-
proved this study (IRB No. IRB3-2016-0317). All the procedures 
performed in the studies involving human participants were 
performed in accordance with the ethical standards of our insti-
tutional and/or national research committees and those of the 
1964 Helsinki Declaration and its later amendments or compa-
rable ethical standards. Since this is a retrospective study, no in-
formed consent was obtained. The medical records of 49 pa-
tients newly diagnosed with unilateral VS from magnetic reso-
nance imaging (MRI) findings between 2014 and 2015 were ret-
rospectively reviewed. Twenty-two of the patients presented 
with vertigo symptoms, and vestibular function tests including 
CDP were performed in 18 patients (male:female=8:10; mean 
age, 57.4±15.0 years). Acute onset group included 6 patients 
(33.3%) who had a history of acute episodes of vertigo within 
recent 3 months, and insidious onset group included 12 patients 
(66.7%) who complained of vertigo/imbalance but without an 
acute episode. The audiovestibular evaluation included pure-
tone audiometry, videonystagmography with bithermal caloric 
tests, and CDP. Subjective symptoms were evaluated using self-
report questionnaires.
Subjective measurements of vertigo
The patients indicated their feeling of dizziness on a vertigo vi-
sual analogue scale (VAS). The VAS is a 10-cm scale ranging 
from 0 (no dizziness) to 10 (maximum dizziness). Dizziness re-
lated handicaps in daily activities was measured using the Kore-
an version of the Dizziness Handicap Inventory (DHI), which 
measures self-perceived handicaps resulting from the functional, 
emotional, and physical aspects of dizziness, using a 25-item 
questionnaire. The DHI-total score ranges from 0 (no dizziness 
handicap) to 100 (maximum dizziness handicap). The DHI 
scores are subcategorized as functional (DHI-F, 36 points), emo-
tional (DHI-E, 36 points), and physical (DHI-P, 28 points). 
MRI and tumor grading 
MRI scans were reviewed and the tumor size was measured on 
contrast-enhanced T1-weighted axial or coronal images. In each 
case, a maximum diameter was measured, and separate mea-
surements for the internal auditory canal (IAC) and cerebello-
   Postural instability is prevalent in vestibular schwannoma (VS) 
patients with acute onset and insidious onset vestibular symp-
toms.
   Computerized dynamic posturography parameters were cor-
related with the tumor size and caloric weakness, but not with 
acute or insidious onset of vertigo. 
   VS patients with insidious onset of vertigo symptoms tended 
to show increased canal weakness and postural instability. 
   Further vestibular evaluation would be useful even in VS pa-
tients who do not experience acute vertigo episodes. 
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pontine angle (CPA) portions were recorded. Also, tumors were 
graded according to Koos et al. [18]: grade I when the tumor is 
in the IAC, grade II when the tumor is in the CPA and <2 cm, 
grade III when the tumor is in the CPA and 2 cm to 4 cm, and 
grade IV if the tumor is in the CPA and >4 cm.
Sensory organization test
A sensory organization test (SOT) was performed on a CDP 
platform (EquiTest; Neurocom, Clackamas, OR, USA). For each 
test, the subjects were requested to stand upright and barefoot 
on the platform and were instructed to look straight ahead at a 
picture located on the visual surround. During the SOT, the par-
ticipant’s task was to maintain an upright stance, as stable as 
possible, during three 20 seconds trials in six conditions that 
combined three visual conditions with two platform conditions. 
The subjects wore a safety harness to protect against falls. An 
equilibrium score (ES) was calculated by comparing the sub-
ject’s anteroposterior sway during each trial to the maximal the-
oretical sway limits of stability, which is based on the individu-
al’s height and size of the support base. Lower sways led to a 
higher ES, indicating a better balance performance (a score of 
100 represented no sway, while 0 indicated sway that exceeded 
the limits of stability, resulting in a fall). The conditions are as 
follows: C1, eyes open and the platform is stationary; C2, eyes 
closed and the platform is stationary; C3, visual surround moves 
and the platform is stationary; C4, eyes open and the platform is 
moving; C5, eyes closed and the platform is moving; C6, visual 
surround is moving and the platform is moving. A composite 
(COMP) score is calculated by independently averaging the ES 
for C1 and C2, then adding them to the ES from each trial of 
C3–C6, and finally dividing this sum by the total number of tri-
als. Each ES was adjusted to ES for C1 to identify the signifi-
cance of each sensory system influencing postural control, ratio 
of C2 to C1 representing the somatosensory contribution to 
postural control (SOM), ratio of C4 to C1 representing the visu-
al contribution, and ratio of C5 to C1 representing the vestibu-
lar contribution (VEST). The ability to rely on visual orientation 
cues for postural control, or visual preference, was evaluated by 
comparing the sway-referenced visual surround with the ab-
sence of vision [(C3+C6)/(C2+C5)]. Each sensory analysis ratio 
was considered “abnormal” when it was lower than the age-
specific normative data given by the CDP manufacturer. The ab-
normal low SOM, visual contribution, and VEST ratio indicate 
that patients make poor use of each sensory system in postural 
stability. A low preference ratio means that patients rely on visu-
al cues even when they are inaccurate (such as in moving visual 
surroundings) [19].
Caloric test
The bithermal caloric test was used, and eye movements were 
recorded by means of a video-based system (VisualEyes video 
nystagmography system; Micromedical Technologies Inc., Cha-
tham, IL, USA). Each ear was irrigated alternately with a con-
stant flow of water at temperatures of 30ºC and 44ºC and for a 
constant period (30 seconds). The maximum slow-phase eye ve-
locity of nystagmus was calculated after each irrigation, and 
Table 1. Clinical characteristics of patients with vestibular schwannoma presenting with vertigo symptoms
Variable All patients (n=18) Acute onset (n=6) Insidious onset (n=12) P-value
Age (yr) 57.4±15.0 66.7±14.3 52.8±13.7 0.062
Sex (male:female) 8:10 5:1 3:9 -
Site (right:left) 9:9 3:3 6:6 -
Tumor size
Maximum size of tumor (mm) 25.3±18.0 15.9±12.4 34.3±15.0 0.020
IAC extension (no. of patients) 16 (88.9) 4 (66.7) 12 (100) -
IAC portion size 7.3±4.3 4.7±4.7 8.6±3.5 0.065
CPA portion size 23.3±16.3 10.3±10.2 29.8±15.1 0.012
Koos classification -
I  3 (16.7) 2 (33.3) 1 (8.3)
II 1 (5.6) 1 (16.7) 0
III 11 (61.1) 3 (50.0)  8 (66.7)
IV  3 (16.7) 0 3 (25.0)
Associated symptom -
Hearing loss in ipsilateral ear 11 (61.1) 4 (66.7) 7 (58.3)
Tinnitus 7 (38.9) 3 (50.0) 4 (33.3)
Facial palsy 5 (27.8) 1 (16.7) 4 (33.3)
PTA (dB HL)
Ipsilateral ear 66.3±34.3 51.5±31.8 73.8±34.3 0.202
Contralateral ear 24.8±26.9 33.5±27.1 20.3±26.9 0.330
Values are presented as mean±standard deviation or number (%).
IAC, internal auditory canal; CPA, cerebellopontine angle; PTA, pure-tone audiometry; HL, hearing level.
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Jongkees’ formula was used to determine canal weakness. Ca-
nal weakness greater than 25% was defined as abnormal.
Data analyses
All statistical analyses were performed using SPSS ver. 12.0 
(SPSS Inc., Chicago, IL, USA). The difference in variables be-
tween the acute onset and insidious onset groups of VS patients 
was tested using Pearson’s chi-square test. Spearman correlation 
analysis was used to identify linear associations between two 
variables. All data are presented as mean±standard deviation. A 
P-value <0.05 was considered to reflect statistically significance.
RESULTS
The clinical characteristics of patients in the acute and chronic 
onset groups are described in Table 1. The tumor size was signifi-
cantly larger for the insidious onset group (mean, 34.3±15.0 
mm) compared to the acute onset group (mean, 15.9±12.4 
mm; P=0.020). Tumor extended into to the IAC in four patients 
(66.7%) of acute onset group and all patients of insidious onset 
group. Although the tumor size for the IAC portion appeared 
larger for the insidious onset group, the difference was not statis-
tically significant. The tumor size for the CPA portion was larger 
for the insidious onset group (P=0.012). Acute onset group in-
cluded grade I, II and III, and insidious onset included one case 
of grade I and others were graded III and IV according to Koos 
classifications. Most commonly associated symptom was hearing 
loss, followed by tinnitus and facial palsy. Hearing thresholds in 
the ipsilateral ears were worse in the insidious onset group, but 
the difference was not statistically significant.
Subjective perception of symptoms severity as measured by 
VAS ranged from mild to severe (1–10), and did not show sig-
nificant difference between the acute onset and insidious onset 
groups (P=0.318). Likewise, the DHI total score or subscale 
scores (DHI-P, E, and F) did not differ between two groups 
(P>0.05). Caloric weakness was noted in 13 of all patients 
(72.2%). All patients showed decreased ES for C5 and C6, and 
resulting VEST and COMP scores were also decreased, support-
ing that postural instability is prevalent in these patients. When 
the acute onset and insidious onset groups were compared, the 
VAS and DHI scores did not show significant difference. The in-
sidious onset group had higher rate of caloric weakness (100%), 
and caloric weakness was greater (P=0.014) than the acute on-
set group (Table 2). 
Correlation between postural instability measured as COMP 
score and other associated factors was examined (Table 3). The 
COMP scores were not correlated with VAS or DHI scores. Tu-
mor sizes (the maximum diameter, IAC or CPA portion sizes) 
did not show significant correlation with COMP scores. Fig. 1 
shows the box-plots to compare variables related to postural in-
stability between the acute onset and insidious onset groups. 
The ES for C5 and C6, VEST and COMP scores were generally 
lower for the insidious onset group compared to acute onset 
group, but the difference was not statistically significant (Fig. 1).
DISCUSSION
Vestibular symptoms in VS patients are widely variable. Al-
though the VS is a slowly-growing tumor, some patients may ex-
perience acute onset of severe vertigo, while others develop 
subtle or no symptoms. Maximum tumor size, nerve of origin, 
Table 2. Comparison of subjective symptom severity and vestibular 
function tests in VS patients with acute onset or insidious onset of 
vertigo symptoms
Variable
All patients 
(n=18)
Acute onset 
(n=6)
Insidious 
onset (n=12) P-value
VAS 4.6±2.4 3.5±3.0 5.0±2.2 0.318
DHI
P subscale 10.3±7.5 10.0±9.4 10.4±7.2 0.627
E subscale 14.7±11.4 15.0±16.7 14.8±9.7 0.978
F subscale 18.3±12.2 18.0±16.5 18.4±11.2 0.958
Total score 43.4±30.0 43.0±42.3 43.6±26.6 0.980
Caloric 
weakness (%)
63.4±34.2 30.8±6.2 77.9±31.1 0.014
CDP parameter
ES C1 92.9±2.3 92.6±2.9 93.1±2.1 0.663
ES C2 91.4±2.4 90.8±3.4 91.8±1.8 0.394
ES C3 88.3±3.7 90.9±4.1 87.0±2.9 0.074
ES C4 72.8±15.7 67.5±24.7 75.4±9.1 0.334
ES C5 45.2±19.8 48.4±25.2 43.6±17.5 0.644
ES C6 39.4±21.7 45.4±24.8 36.5±20.5 0.431
COMP 65.9±11.0 68.7±13.1 64.6±10.1 0.474
SOM 1.0±0.0 1.0±0.0 1.0±0.0 0.616
VIS 0.8±0.2 0.7±0.3 0.8±0.1 0.368
VEST 0.5±0.2 0.5±0.3 0.5±0.2 0.641
PREF 0.9±0.1 1.0±0.1 0.9±0.1 0.138
Values are presented as mean±standard deviation.
VS, vestibular schwannoma; VAS, visual analogue scale; DHI, Dizziness 
Handicap Inventory; P, physical; E, emotional; F, functional; CDP, comput-
erized dynamic posturography; ES, equilibrium score; C, condition; 
COMP, composition; SOM, somatosensory; VIS, visual; VEST, vestibular; 
PREF, preference.
Table 3. The correlation between the COMP scores and associated 
factors in VS patients
Variable COMP
Spearman correlation 
coefficient
Tumor size P=0.632 R=–0.121
VAS P=0.547 R=0.176
DHI total score P=0.753 R=0.093
Canal weakness P=0.167 R=–0.408
COMP, composition; VS, vestibular schwannoma; VAS, visual analogue 
scale; DHI, Dizziness Handicap Inventory. 
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associated cochlear symptoms and objective vestibular function 
test results have been investigated for their correlation of symp-
tom severity of vertigo and imbalance. However, little is known 
about acute onset of symptoms in VS patients. It has been sur-
mised that acute change in tumor size, such as tumor growth or 
intratumoral hemorrhage or cystic change would compress the 
vestibular nerves or cerebellum leading to acute vestibular 
symptoms. Direct compression of the vestibular nerves would 
lead to demyelination, and also decreased microcirculation 
would damage the neural structures. In addition, metabolic 
changes caused by tumoral secretions from VS have been related 
to cochlear damage causing sensorineural hearing loss, and simi-
lar effects on vestibular organs may contribute to their abrupt or 
gradual loss of function [20]. 
In this study, we aimed to investigate whether tumor charac-
teristics and vestibular functional status of vestibular system and 
postural control are related to acute onset or insidious onset of 
vertigo. Our results showed that the maximum size of tumor 
and the IAC and CPA portion sizes were larger, hearing impair-
ment was more common, and canal weakness was greater in pa-
tients with insidious onset of vestibular symptoms. It can be 
suggested that acute onset of vertigo is not related to tumor size. 
Sudden change in vestibular sensory input, possibly by mechani-
cal or biochemical damage can be postulated as possible expla-
nation for acute bouts of vertigo. Considering that caloric weak-
ness was more evident in the insidious onset group, acute onset 
of symptoms may reflect acute deterioration of residual vestibu-
lar function. While the insidious onset group showed greater ca-
loric weakness, gradual vestibular compensation in these pa-
tients might explain the lack of difference in SOT parameters 
compared to acute onset vertigo group. However, it remains a 
question whether the direct compression of the nerves can be 
deduced from tumor size measurements, and a longitudinal fol-
low-up study of VS patients with IAC involvement to correlate 
changes in tumor dimensions in the IAC and development of 
acute vertigo symptoms would be informative. Another expla-
nation is that the proximity of the tumor to the inner ear in VS 
patients with IAC involvement would facilitate diffusion of me-
tabolites that cause cochlear and vestibular damage. However, 
VS-secreted metabolites have been identified only recently, and 
their possible effect on vestibular organs are still unknown. 
The CDP is widely employed, and the SOT paradigm pro-
vides essential information regarding a patient’s ability to main-
tain stable posture. While static balance tests such as the Rom-
Fig. 1. Box-plots of postural instability-related variables: (A) ES C5, (B) ES C6, (C) VEST, and (D) COMP scores for the acute onset and insidi-
ous onset groups of vestibular schwannoma patients. Each box represents the lower (the 25th percentile) to the upper range (the 75th percen-
tile) and contains the median value shown as a line across. The “whiskers” of the box extend to the farthest points that are not outliers (i.e., 
they are within 1.5 times the interquartile range of the 25th and 75th percentiles). Outside values are depicted as circle lines. ES, equilibrium 
score; C, condition; VEST, vestibular; COMP, composition.
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berg test or standing on a foam are simpler to perform in a clin-
ic, the CDP offers the obvious advantage to assess sensory inte-
gration in sensory conflict situations, by altering the visual and 
proprioceptive inputs in six different conditions. Previous stud-
ies have reported that the ES for SOT conditions C5 and C6 are 
related to canal paresis as measured by caloric or rotational 
chair tests in the VS patients [6] and whether they complain of 
vertigo symptoms [16]. Gait disturbance was noted in patients 
with small tumors, especially while walking with eyes closed 
[21]. Postural instability impacts daily activities, and it has been 
shown that the vestibular symptoms correlate with prospective 
working disability in VS patients [8]. These findings support im-
plantation of CDP in vestibular function evaluation of VS pa-
tients. In our analysis, we focused on ES for C5 and 6, COMP 
and VEST scores: the C5 and C6 conditions test the patients’ 
ability to maintain posture relying on vestibular sensory inputs, 
and VEST and COMP scores takes ES for C5 and/or C6 into 
consideration. Dynamic postural instability measured by these 
parameters did not differ between patients with acute or insidi-
ous symptoms. Interestingly, there was a tendency of increased 
postural instability in patients with insidious onset, but the dif-
ference was not statistically significant. With slow growth of tu-
mors and gradual deterioration of vestibular inputs, central 
compensation would take place and alleviate expected acute 
symptoms, and it is plausible that some patients would experi-
ence intermittent or subtle imbalance. Indeed, many patients 
would vaguely describe their symptoms as vertigo or imbalance 
that occurs “sometimes, but not always” over some period of 
time. Since many are referred after diagnosis of VS, the patients 
were already apprehensive about their conditions and some-
times they would not bring up subtle vertigo complaints unless 
asked. During initial interviews with patients who visited our 
tertiary-referral clinic, we asked specific questions regarding 
hearing status and vertigo symptoms. Our results show even 
these nonspecific symptoms should alert the clinician to suspect 
postural instability and consider CDP testing. 
Evaluation of vestibular function and posture control in VS 
patients is important because their prominent effect on patients’ 
quality of life. In patients with untreated VS, vertigo symptoms 
negatively affected quality of life, while hearing symptoms were 
less damaging [22]. Also, vertigo symptoms were more associat-
ed with disability affecting VS patients’ working status after 
treatment than hearing problems [8]. While hearing loss and fa-
cial nerve dysfunction can be measured easily, vestibular tests 
often require more expertise and attention. Furthermore, clini-
cians may be focused to utilize vestibular function tests as tools 
to estimate tumor size, nerve of origin and treatment outcomes, 
which are essential in treatment planning. In addition to these 
pertinent information, patients’ performance in posture control 
should also be considered as an important index of their general 
well-being. 
Limitations of this study include that only VS patients with 
subjective vertigo symptoms were evaluated for postural insta-
bility. About half of the newly diagnosed VS patients did not 
have vestibular symptoms and CDP was not tested, and further 
vestibular evaluation would have been valuable to confirm sub-
clinical vestibular dysfunction. In addition to the conventional 
caloric test, VEMP and vHIT would have provided more com-
prehensive description of vestibular function status, and their 
correlation with postural instability remains to be explored. Pro-
spective longitudinal studies on larger groups of VS patients 
would provide more detailed information regarding postural in-
stability and their symptom correlation.
 This study was aimed to examine factors associated with sub-
jective vestibular symptoms and postural instability in VS pa-
tients. The patients with insidious onset of vertigo symptoms 
tended to show increased canal weakness and postural instabili-
ty. Thus, clinicians should consider that postural instability is 
likely present even in patients who do not complain of acute 
vertigo, and appropriate counseling should be discussed with 
the patients.
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